{{Rsnum
|rsid=762550
|Gene=CRYAB
|Chromosome=11
|position=111912376
|Orientation=minus
|GMAF=0.2842
|Gene_s=CRYAB,HSPB2,HSPB2-C11orf52
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 15.0 | 55.8 | 29.2
| HCB | 4.4 | 40.4 | 55.1
| JPT | 1.8 | 30.1 | 68.1
| YRI | 4.1 | 26.5 | 69.4
| ASW | 7.0 | 26.3 | 66.7
| CHB | 4.4 | 40.4 | 55.1
| CHD | 3.7 | 31.5 | 64.8
| GIH | 20.8 | 52.5 | 26.7
| LWK | 3.6 | 30.9 | 65.5
| MEX | 5.3 | 40.4 | 54.4
| MKK | 2.6 | 31.4 | 66.0
| TSI | 7.9 | 49.5 | 42.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=22537749
|Title=CRYAB-650 C&gt;G (rs2234702) affects susceptibility to Type 1 diabetes and IAA-positivity in Swedish population
}}

{{PMID Auto
|PMID=17601350
|Title=A genetic association analysis of cognitive ability and cognitive ageing using 325 markers for 109 genes associated with oxidative stress or cognition.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}